-
Product Insights
Adrenal Gland Cancer - Drugs In Development, 2024
Empower your strategies with our Adrenal Gland Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Adrenal gland cancer is a rare type of neuroendocrine tumor that originates from the cells of the adrenal glands, which are located on top of the kidneys. The adrenal glands produce hormones that regulate various functions in the body, such as blood pressure, metabolism, stress response, and sex drive. Adrenal gland cancer can affect the production of these hormones, causing symptoms...
-
Product Insights
Anaplastic Thyroid Cancer - Drugs In Development, 2024
Empower your strategies with our Anaplastic Thyroid Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Anaplastic thyroid cancer (ATC) is a rare and aggressive form of thyroid cancer that affects mainly older people. It grows very fast and often spreads to other parts of the body, such as the lungs, bones, and brain. It causes symptoms like a large and painful neck mass, difficulty swallowing or breathing, hoarseness, and cough. The cause of ATC is unknown,...
-
Product Insights
Cancer Anorexia-Cachexia Syndrome - Drugs In Development, 2024
Empower your strategies with our Cancer Anorexia-Cachexia Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Cancer anorexia-cachexia syndrome is defined as progressive weight loss associated with malignancy and is characterized by loss of appetite (anorexia), skeletal muscle wasting, and reduced adipose tissue. Approximately 50% of cancer patients report abnormalities of eating behavior at the time of first diagnosis and prevalence is even higher at approximately 65%. The incidence of weight loss upon diagnosis varies greatly according...
-
Product Insights
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Drugs In Development, 2024
Empower your strategies with our Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) – Drugs In Development, 2024 report and make more profitable business decisions. Malignant peripheral nerve sheath tumors (MPNSTs) are sarcomas that originate from peripheral nerves or from cells associated with the nerve sheath, such as Schwann cells, perineural cells, or fibroblasts. Symptoms include a lump or swelling in the in the soft tissue, numbness, burning, tingling or pins and needles, weakness of the affected muscles, and dizziness or loss of balance....
-
Product Insights
Dedifferentiated Liposarcoma - Drugs In Development, 2024
Empower your strategies with our Dedifferentiated Liposarcoma – Drugs In Development, 2024 report and make more profitable business decisions. Dedifferentiated liposarcoma (DDLPS) is a rare and aggressive type of cancer that arises from fat cells. It usually occurs in the limbs or the abdomen, and can cause pain, swelling, or a lump under the skin. DDLPS is a subtype of liposarcoma that develops from a low-grade tumor called well-differentiated liposarcoma (WDLS). The tumor undergoes a transformation to a high-grade sarcoma that...
-
Product Insights
Lymphoblastic Lymphoma - Drugs In Development, 2024
Empower your strategies with our Lymphoblastic Lymphoma – Drugs In Development, 2024 report and make more profitable business decisions. Lymphoblastic lymphoma (LL) is a rare and aggressive type of non-Hodgkin lymphoma (NHL) that affects immature lymphocytes called lymphoblasts. It can originate from either B-cell or T-cell lymphoblasts, but it is more common in T cells. LL usually involves the lymph nodes in the chest, but it can also affect the bone marrow, the brain and spinal cord, and other organs. LL...
-
Product Insights
Papillary Thyroid Cancer - Drugs In Development, 2024
Empower your strategies with our Papillary Thyroid Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Papillary thyroid cancer (PTC) is the most common type of thyroid cancer, accounting for 75% to 85% of all cases. It affects more women than men and can occur at any age, but especially between 30 and 50 years old. PTC is usually slow-growing and well-differentiated, meaning it resembles normal thyroid cells. However, it can also spread to the lymph nodes...
-
Product Insights
Nodal Marginal Zone B-Cell Lymphoma - Drugs In Development, 2024
Empower your strategies with our Nodal Marginal Zone B-Cell Lymphoma – Drugs In Development, 2024 report and make more profitable business decisions. Nodal marginal zone B-cell lymphoma (NMZL) is a rare type of non-Hodgkin lymphoma that affects the lymph nodes. It is a slow-growing cancer that can sometimes become aggressive. NMZL is more common in older adults, but it can occur in younger people as well. The exact cause of NMZL is unknown, but some genetic factors may be involved. NMZL...
-
Product Insights
Neuroendocrine Carcinoma - Drugs In Development, 2024
Empower your strategies with our Neuroendocrine Carcinoma – Drugs In Development, 2024 report and make more profitable business decisions. Neuroendocrine carcinoma (NEC) is a rare type of cancer that arises from neuroendocrine cells, which are cells that have both nerve and hormone functions. NEC can occur in various organs, such as the lungs, pancreas, stomach, intestines, appendix, rectum, breast, kidney, ovaries, or testicles. NEC can be classified into well-differentiated or poorly differentiated tumors, depending on how they look under the microscope...
-
Product Insights
Splenic Marginal Zone B-Cell Lymphoma - Drugs In Development, 2024
Empower your strategies with our Splenic Marginal Zone B-Cell Lymphoma – Drugs In Development, 2024 report and make more profitable business decisions. Splenic marginal zone lymphoma (SMZL) is a rare type of B-cell lymphoma that affects the spleen, bone marrow, and sometimes the blood. It is a low-grade neoplasm that originates from the germinal centers of the splenic white pulp. The neoplastic cells are small lymphocytes and larger transformed lymphoblasts that invade the mantle and marginal zones of the spleen and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.